XML 33 R23.htm IDEA: XBRL DOCUMENT

SHAREHOLDERS' EQUITY (Tables)

3 Months Ended

Nov. 30, 2023

Shares Outstanding

Shares of Company's common stock outstanding for the three months ended November 30, 2023 and 2022 were as follows:



	Three Months Ended November 30,
(in thousands)		2023	2022
Common stock outstanding, beginning of period		19,938	20,260

Common stock issued during the period		28	54
Common stock outstanding, end of period		19,966	20,314

Schedule of Dividends Payable

Dividends

The Company’s Board of Directors declared cash dividends during the fiscal years 2024 and 2023. The details of dividends paid are in the following tables:

(in thousands, except dividend per share)

Fiscal Year 2024

Record Date

Distribution Date

Number of Shares
Outstanding on
Record Date

Dividend per
Share

Total Amount

10/30/2023

11/06/2023

19,939

0.06

1,196


(in thousands, except dividend per share)	Fiscal Year 2023

Record Date	Distribution Date	Number of Shares Outstanding on Record Date	Dividend per Share		Total Amount
10/31/2022	11/07/2022	20,299	$	0.06	$	1,218
1/30/2023	2/06/2023	19,924	$	0.06	1,195
4/24/2023	5/01/2023	19,999	$	0.06	1,200
7/31/2023	8/07/2023	19,931	$	0.06	1,196
Total					$	4,809

Share-based Payment Arrangement, Option, Activity

The following tables summarize information about stock options:


(in thousands, except per share and weighted-average amounts)
Activity for the three months ended November 30, 2023	Number of Options	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life
Outstanding, August 31, 2023	1,478	$	34.62	6.62 years
Granted	482	39.98
Exercised	(26)	9.78
Canceled/Forfeited	(7)	45.64
Outstanding, November 30, 2023	1,927	$	36.25	7.30 years
Vested and Exercisable, November 30, 2023	809	$	28.06	5.10 years
Vested and Expected to Vest, November 30, 2023	1,844	$	36.06	7.19 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

The following table summarizes the fair value of the options, including both ISOs and NQSOs, granted during the three month period ended November 30, 2023 and fiscal year 2023:


(in thousands, except weighted-average amounts)	Three Months Ended November 30, 2023			Fiscal Year 2023
Estimated fair value of awards granted	$	9,552		$	10,067
Unvested Forfeiture Rate	6.38		%	0.22		%
Weighted-average grant price	$	39.98		$	43.78
Weighted-average market price	$	39.98		$	43.78
Weighted-average volatility	44.79		%	46.14		%
Weighted-average risk-free rate	4.93		%	4.29		%
Weighted-average dividend yield	0.60		%	0.55		%
Weighted-average expected life	6.59 years			6.55 years

Share-based Payment Arrangement, Option, Exercise Price Range

The exercise prices for the options outstanding at November 30, 2023, ranged from $6.85 to $66.14, and the information relating to these options are as follows:

(in thousands except prices and weighted-average amounts)


Exercise Price				Awards Outstanding				Awards Exercisable
Low		High		Quantity	Weighted -Average Remaining Contractual Life	Weighted-Average Exercise Price		Quantity	Weighted-Average Remaining Contractual Life	Weighted-Average Exercise Price
$	6.85	$	9.77	182	1.81 years	$	8.89	182	1.81 years	$	8.89
$	9.78	$	18.76	148	3.24 years	$	10.10	148	3.24 years	$	10.10
$	18.77	$	33.40	200	5.39 years	$	25.37	137	5.29 years	$	24.60
$	33.41	$	47.63	1,125	9.06 years	$	41.21	212	7.90 years	$	40.94
$	47.64	$	66.14	272	7.31 years	$	56.33	130	7.05 years	$	58.00
				1,927	7.30 years	$	36.25	809	5.10 years	$	28.06